5-Aza-2'-deoxycytidine (NSC 127716) in non-seminomatous testicular cancer. Phase II from the EORTC Early Clinical Trials Cooperative Group and Genito-Urinary Group

Ann Oncol. 1992 May;3(5):399-400. doi: 10.1093/oxfordjournals.annonc.a058216.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Azacitidine / adverse effects
  • Azacitidine / analogs & derivatives*
  • Azacitidine / therapeutic use
  • Decitabine
  • Drug Evaluation
  • Dysgerminoma / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Testicular Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Decitabine
  • Azacitidine